Christoph Krähenbühl, senior director at 3C Excellis Europe, talks to EPM about Europe’s readiness for the EU falsified medicines directive (EU FMD).
This month sees an important milestone for all pharmaceutical manufacturers supplying the European market and their supply chain partners: 9 February 2017 marks the beginning of the two-year countdown until the EU FMD comes into force across Europe.